| Term | Count | % | | TREATMENT FAILURE | 5895 | 7.30% |
| DRUG INEFFECTIVE | 3098 | 3.84% |
| EYE IRRITATION | 2333 | 2.89% |
| FATIGUE | 2115 | 2.62% |
| INTRAOCULAR PRESSURE INCREASED | 1822 | 2.26% |
| HEADACHE | 1660 | 2.06% |
| EYE PAIN | 1595 | 1.98% |
| DYSPNOEA | 1561 | 1.93% |
| DEATH | 1556 | 1.93% |
| VISION BLURRED | 1535 | 1.90% |
| DIZZINESS | 1531 | 1.90% |
| DIARRHOEA | 1494 | 1.85% |
| NAUSEA | 1475 | 1.83% |
| OFF LABEL USE | 1455 | 1.80% |
| OCULAR HYPERAEMIA | 1389 | 1.72% |
| FALL | 1361 | 1.69% |
| CATARACT | 1357 | 1.68% |
| GLAUCOMA | 1326 | 1.64% |
| PAIN | 1212 | 1.50% |
| ASTHENIA | 1207 | 1.49% |
| HYPERSENSITIVITY | 1150 | 1.42% |
| MALAISE | 981 | 1.21% |
| RASH | 975 | 1.21% |
| VISUAL IMPAIRMENT | 974 | 1.21% |
| PNEUMONIA | 941 | 1.17% |
| PRURITUS | 910 | 1.13% |
| WEIGHT DECREASED | 894 | 1.11% |
| CONDITION AGGRAVATED | 886 | 1.10% |
| PAIN IN EXTREMITY | 869 | 1.08% |
| ARTHRALGIA | 864 | 1.07% |
| COUGH | 842 | 1.04% |
| VOMITING | 820 | 1.02% |
| HYPERTENSION | 813 | 1.01% |
| EYE PRURITUS | 773 | 0.96% |
| DRUG HYPERSENSITIVITY | 748 | 0.93% |
| VISUAL ACUITY REDUCED | 728 | 0.90% |
| CONSTIPATION | 693 | 0.86% |
| DRY EYE | 689 | 0.85% |
| INSOMNIA | 660 | 0.82% |
| PYREXIA | 657 | 0.81% |
| CONFUSIONAL STATE | 652 | 0.81% |
| EYE DISORDER | 650 | 0.80% |
| PRODUCT DOSE OMISSION ISSUE | 615 | 0.76% |
| DEPRESSION | 614 | 0.76% |
| DECREASED APPETITE | 609 | 0.75% |
| BACK PAIN | 602 | 0.75% |
| PRODUCT QUALITY ISSUE | 586 | 0.73% |
| CEREBROVASCULAR ACCIDENT | 577 | 0.71% |
| ACUTE KIDNEY INJURY | 575 | 0.71% |
| SOMNOLENCE | 555 | 0.69% |
| URINARY TRACT INFECTION | 553 | 0.68% |
| ANAEMIA | 541 | 0.67% |
| GAIT DISTURBANCE | 539 | 0.67% |
| INCORRECT DOSE ADMINISTERED | 522 | 0.65% |
| FEELING ABNORMAL | 508 | 0.63% |
| BLOOD PRESSURE INCREASED | 506 | 0.63% |
| CHEST PAIN | 506 | 0.63% |
| HYPOTENSION | 503 | 0.62% |
| ANXIETY | 499 | 0.62% |
| ERYTHEMA | 494 | 0.61% |
| PALPITATIONS | 481 | 0.60% |
| LACRIMATION INCREASED | 478 | 0.59% |
| COVID-19 | 468 | 0.58% |
| BLINDNESS | 464 | 0.57% |
| ABDOMINAL DISCOMFORT | 462 | 0.57% |
| MYALGIA | 455 | 0.56% |
| ATRIAL FIBRILLATION | 441 | 0.55% |
| PERIPHERAL SWELLING | 437 | 0.54% |
| DRUG INTOLERANCE | 434 | 0.54% |
| RENAL FAILURE | 429 | 0.53% |
| MUSCLE SPASMS | 427 | 0.53% |
| PRODUCT USE ISSUE | 427 | 0.53% |
| NASOPHARYNGITIS | 422 | 0.52% |
| TREMOR | 422 | 0.52% |
| ARTHRITIS | 421 | 0.52% |
| HAEMOGLOBIN DECREASED | 418 | 0.52% |
| OEDEMA PERIPHERAL | 415 | 0.51% |
| PRODUCT USE IN UNAPPROVED INDICATION | 413 | 0.51% |
| ABDOMINAL PAIN UPPER | 392 | 0.49% |
| ABDOMINAL PAIN | 389 | 0.48% |
| ALOPECIA | 382 | 0.47% |
| BRONCHITIS | 382 | 0.47% |
| DEHYDRATION | 377 | 0.47% |
| WEIGHT INCREASED | 376 | 0.47% |
| MUSCULAR WEAKNESS | 373 | 0.46% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 368 | 0.46% |
| EYE SWELLING | 363 | 0.45% |
| MYOCARDIAL INFARCTION | 358 | 0.44% |
| SYNCOPE | 354 | 0.44% |
| FOREIGN BODY SENSATION IN EYES | 350 | 0.43% |
| MEMORY IMPAIRMENT | 349 | 0.43% |
| PARAESTHESIA | 339 | 0.42% |
| BALANCE DISORDER | 334 | 0.41% |
| CARDIAC FAILURE CONGESTIVE | 334 | 0.41% |
| DYSGEUSIA | 334 | 0.41% |
| HYPOAESTHESIA | 332 | 0.41% |
| BLOOD GLUCOSE INCREASED | 330 | 0.41% |
| VERTIGO | 327 | 0.40% |
| DRUG INTERACTION | 324 | 0.40% |
| ASTHMA | 323 | 0.40% |
| Total | 80754 | |